The Courtyard Connection

The Courtyard Connection Built around the sides of a quad in Jülich, the four institutes of the Center for Microbial Biotechnology move forward inspired by a fruitful linkage and legacy. By Nicola Kuhrt A 30 liter bioreactor in the microbial cultivation lab of the Institute of Biotechnology. An engineer is inspecting the bioreactor operation during the cultivation experiment. © Research center Jülich Karl-Erich

Written byNicola Kuhrt
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

By Nicola Kuhrt

Karl-Erich Jaeger knows the 60-kilometer stretch of country between Jülich and Düsseldorf like the back of his hand. At least twice a week, the professor of molecular biology leaves Jülich and his workplace at the Research Center on a drive past fields of sugar beet, through the Garzweiler brown-coal mining area, and past Dyck Castle to the capital of North Rhine-Westphalia (NRW), Düsseldorf. As a professor at the University of Dusseldorf and head of the Institute of Molecular Enzyme Technology (IMET) his time is divided between research on enzymes derived from bacteria in Jülich and lecturing at the university.

There is a good reason why IMET is not on the university premises but on the campus of the Jülich Research Center: its breadth of expertise. Jülich is Germany's biggest nonuniversity research institution and one of the largest interdisciplinary research centers in Europe. IMET is only one of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies